- Filed
- Aug 8, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 1, 2024 | 36.52M sh |
| Short Term Investments | Q2 2024 · Jun 30, 2024 | $320.16M |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $280.74M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $251.1M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $251.18M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $34.67M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $40.01M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $87.97M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $92.36M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $626.61M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $550.65M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $751.84M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $667.59M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 35.77M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 35.74M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $819K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$56.1M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $623.53M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $652.26M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $663.33M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$0.96 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | −$1.39 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$0.96 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | −$1.39 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $13.44M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $25.39M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $29.19M |
| Rd Expense | Q2 2024 · Jun 30, 2023 | $54.89M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$34.3M |
| Net Income | Q2 2024 · Jun 30, 2023 | −$49.85M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$15.55M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$42.62M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$67.68M |
| Revenue | Q2 2024 · Jun 30, 2023 | $0 |
| Revenue | Q2 2024 · Jun 30, 2023 | $12.6M |